Share your thoughts on our News & Insights section. Complete our survey to help us improve.

Share research

Fevertree: first-half sales fall short of expectations

Fevertree’s had a tough start to the year, and full-year sales targets have been wound back as a result.
Fevertree - US market fuels sales growth

No recommendation - No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

Prices delayed by at least 15 minutes

Fevertree’s first-half revenue was broadly flat at £172.9mn ignoring currency impacts, which fell short of market expectations.

Double-digit revenue growth in the US and the Rest of the World was offset by declines in the UK and Europe, where unfavourable weather in the second quarter and the timing of shipments weighed on performance. Despite this, Fevertree gained market share across all regions.

Underlying operating profit rose from £0.6mn to £12.2mn as shipping rates, energy costs, and wider inflationary pressures eased.

Free cash flow improved from an outflow of £7.3mn to an inflow of £22.1mn. Net cash, including lease liabilities, was £59.7mn at the half-year mark.

Markets are now expecting full-year revenue to grow by 2-3%, down from the 8% growth management guided to at start of the year.

An interim dividend of 5.85p per share was announced, up 2%.

The shares fell 6.7% following the announcement.

Our view

HL view to follow.

Fevertree key facts

All ratios are sourced from Refinitiv, based on previous day’s closing values. Please remember yields are variable and not a reliable indicator of future income. Keep in mind key figures shouldn’t be looked at on their own – it’s important to understand the big picture.

This article is original Hargreaves Lansdown content, published by Hargreaves Lansdown. It was correct as at the date of publication, and our views may have changed since then. Unless otherwise stated estimates, including prospective yields, are a consensus of analyst forecasts provided by Refinitiv. These estimates are not a reliable indicator of future performance. Yields are variable and not guaranteed. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment.No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment.This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication.Non - independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place(including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing.Please see our full non - independent research disclosure for more information.
Latest from Share research
Weekly Newsletter
Sign up for Share Insight. Get our Share research team’s key takeaways from the week’s news and articles direct to your inbox every Friday.
Written by
Aarin Chiekrie
Aarin Chiekrie
Equity Analyst

Aarin is a member of the Equity Research team. Alongside our other analysts, he provides regular research and analysis on individual companies and wider sectors. Having a keen interest in global economics, he knows how macro-events can impact individual companies.

Our content review process
The aim of Hargreaves Lansdown's financial content review process is to ensure accuracy, clarity, and comprehensiveness of all published materials
Article history
Published: 12th September 2024